Aug 25, 2023

Financing 25.08.2023 Private Equity backed SpiTrex Orthopedics, a leader in global medical device contract manufacturing, acquired Watershed Idea Foundry, experts in titanium additive manufacturing (AM). SpiTrex Orthopedics, founded in 2014 and headquartered in Le Locle, can expand its services to include 3D printing. In 2014, SpiTrex Orthopedics was created through a management buyout of a Biomet subsidiary in Le Locle. After attracting Ekkio Capital as an investor in 2019, SpiTrex has already acquired two US companies. With Watershed Idea Foundry, another company from the USA is now added to the group. As an organization focused on growth and innovation, the acquisition of Watershed plays a critical role in the expansion of SpiTrex, as they aim to strengthen their commitment to world-class services, particularly in the area of 3D printing. As a part of the transition, Watershed is rebranding as SpiTrex 3D. "The acquisition of Watershed Ideas Foundry is a crucial next step in SpiTrex Orthopedics' desire to be the premier CDMO in the Spine, Trauma, and Extremity market. Additive Manufacturing is an exciting technology with ever-increasing applications and uses, so it was obvious to us that SpiTrex needed to acquire this technology into our portfolio. The extensive Design for Additive Manufacturing experience of the Watershed team and the fact that they maintain FDA Master Files for their additive processes will make us an extremely competitive option for our customers who want to get to market fast", commented Matt Burba, SpiTrex Orthopedic's CEO. According to Matt Burba, the acquisition of Watershed Idea Foundry expands its contract manufacturing offering to create a total end-to-end AM solution. This solution supports research and product development, prototyping, manufacturing, inspection and quality, complete packaging, and delivery of complex finished products. SpiTrex Orthopedics is an international contract manufacturer with a specific focus on complex orthopedic implants for the Spine, Trauma, and Extremity markets (Spi.Tr.Ex.). Its multi-site footprint consists of 4 manufacturing locations: and SpiTrex Switzerland (Le Locle, CH), SpiTrex CTE (Plymouth, IN), SpiTrex MDI (Lancaster, PA), and SpiTrex 3D (Carlsbad, CA). (Press release / SK)